“… findings support current guidelines against routine use, but strong recommendations are not warranted because confidence in the effect estimates is limited.”
Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Systematic Review and Meta-Analysis. Evaniew et al. Journal of Neurotrauma, Feb. 2016. Link to the abstract here.